For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
We are committed to advancing hemophilia patient care and facilitating the development of novel treatments through research studies and clinical trials. The development of new strategies, including disease-modifying and curative therapies, form the basis of our progressive approach to hemophilia management for patients at Weill Cornell Medicine.